Event: UEG 2024
Vienna, Austria, 13 - 15 Oct 2024
We will be attending UEG 2024 in Vienna. This event brings the international and multidisciplinary community of digestive health professionals to discuss the latest advancements and news in the field.
We will be presenting two posters:
- Targeted Breath Biopsy® profiling of induced biomarkers unveils a metabolic adaptation in cirrhosis toward alcohol production
- Breath-based monitoring of microbiome metabolic responses before and after ingestion of nutrients
If you would like to meet our team at this event to discuss incorporating breath based biomarkers into your research, please get in touch.
Meet the team attending UEG
Elizabeth Crone
Dr Elizabeth Crone, Head of Business Development, Research Products and Services, Europe and ROW, will be attending and presenting at this event. Liz has a strong technical background, with a biochemistry degree from Leeds University and a PhD from the University of Cambridge in biophysical chemistry, as well as several years consulting experience on technical innovation projects for companies like J&J, P&G and Shell. For the last decade, she has focussed on her passion: helping companies with potentially life-changing innovative technologies bring them to where they can be most useful. Liz now works in Owlstone as Head of Business Development for Research Products and Services in Europe. She works with European-based companies and leading academics to help them explore and utilize breath as a biomarker matrix to advance their research.
Dr Ben Constant
Dr Ben Constant is a Business Development Executive at Owlstone Medical, where he is dedicated to advancing breath biomarker research.
Ben completed his undergraduate studies in Biomedical Sciences at the University of Sheffield, before pursuing a PhD at the University of Cambridge under the supervision of Dr Wei Li in the Department of Medicine. His doctoral research focused on elucidating the mechanisms of action of a novel pharmaceutical treatment for obesity.
Ben has a diverse background in the medical technology sector. He previously worked at Ortho Clinical Diagnostics, where he contributed to the development of a diagnostic test for heart attacks. Additionally, he has served as a technical consultant, assisting MedTech innovators in bringing their cutting-edge technologies to market.
In his current role, Ben is passionate about collaborating with leading scientists across Europe and Asia, helping them explore how breath biomarkers can enhance their research and clinical outcomes.
